These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 29655704)
1. A Library of Phosphoproteomic and Chromatin Signatures for Characterizing Cellular Responses to Drug Perturbations. Litichevskiy L; Peckner R; Abelin JG; Asiedu JK; Creech AL; Davis JF; Davison D; Dunning CM; Egertson JD; Egri S; Gould J; Ko T; Johnson SA; Lahr DL; Lam D; Liu Z; Lyons NJ; Lu X; MacLean BX; Mungenast AE; Officer A; Natoli TE; Papanastasiou M; Patel J; Sharma V; Toder C; Tubelli AA; Young JZ; Carr SA; Golub TR; Subramanian A; MacCoss MJ; Tsai LH; Jaffe JD Cell Syst; 2018 Apr; 6(4):424-443.e7. PubMed ID: 29655704 [TBL] [Abstract][Full Text] [Related]
2. Getting Started with LINCS Datasets and Tools. Xie Z; Kropiwnicki E; Wojciechowicz ML; Jagodnik KM; Shu I; Bailey A; Clarke DJB; Jeon M; Evangelista JE; V Kuleshov M; Lachmann A; Parigi AA; Sanchez JM; Jenkins SL; Ma'ayan A Curr Protoc; 2022 Jul; 2(7):e487. PubMed ID: 35876555 [TBL] [Abstract][Full Text] [Related]
3. Proteomic profiling dataset of chemical perturbations in multiple biological backgrounds. Dele-Oni DO; Christianson KE; Egri SB; Vaca Jacome AS; DeRuff KC; Mullahoo J; Sharma V; Davison D; Ko T; Bula M; Blanchard J; Young JZ; Litichevskiy L; Lu X; Lam D; Asiedu JK; Toder C; Officer A; Peckner R; MacCoss MJ; Tsai LH; Carr SA; Papanastasiou M; Jaffe JD Sci Data; 2021 Aug; 8(1):226. PubMed ID: 34433823 [TBL] [Abstract][Full Text] [Related]
4. Reduced-representation Phosphosignatures Measured by Quantitative Targeted MS Capture Cellular States and Enable Large-scale Comparison of Drug-induced Phenotypes. Abelin JG; Patel J; Lu X; Feeney CM; Fagbami L; Creech AL; Hu R; Lam D; Davison D; Pino L; Qiao JW; Kuhn E; Officer A; Li J; Abbatiello S; Subramanian A; Sidman R; Snyder E; Carr SA; Jaffe JD Mol Cell Proteomics; 2016 May; 15(5):1622-41. PubMed ID: 26912667 [TBL] [Abstract][Full Text] [Related]
5. Compound signature detection on LINCS L1000 big data. Liu C; Su J; Yang F; Wei K; Ma J; Zhou X Mol Biosyst; 2015 Mar; 11(3):714-22. PubMed ID: 25609570 [TBL] [Abstract][Full Text] [Related]
6. Drug Signature Detection Based on L1000 Genomic and Proteomic Big Data. Chen W; Zhou X Methods Mol Biol; 2019; 1939():273-286. PubMed ID: 30848467 [TBL] [Abstract][Full Text] [Related]
7. The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations. Keenan AB; Jenkins SL; Jagodnik KM; Koplev S; He E; Torre D; Wang Z; Dohlman AB; Silverstein MC; Lachmann A; Kuleshov MV; Ma'ayan A; Stathias V; Terryn R; Cooper D; Forlin M; Koleti A; Vidovic D; Chung C; Schürer SC; Vasiliauskas J; Pilarczyk M; Shamsaei B; Fazel M; Ren Y; Niu W; Clark NA; White S; Mahi N; Zhang L; Kouril M; Reichard JF; Sivaganesan S; Medvedovic M; Meller J; Koch RJ; Birtwistle MR; Iyengar R; Sobie EA; Azeloglu EU; Kaye J; Osterloh J; Haston K; Kalra J; Finkbiener S; Li J; Milani P; Adam M; Escalante-Chong R; Sachs K; Lenail A; Ramamoorthy D; Fraenkel E; Daigle G; Hussain U; Coye A; Rothstein J; Sareen D; Ornelas L; Banuelos M; Mandefro B; Ho R; Svendsen CN; Lim RG; Stocksdale J; Casale MS; Thompson TG; Wu J; Thompson LM; Dardov V; Venkatraman V; Matlock A; Van Eyk JE; Jaffe JD; Papanastasiou M; Subramanian A; Golub TR; Erickson SD; Fallahi-Sichani M; Hafner M; Gray NS; Lin JR; Mills CE; Muhlich JL; Niepel M; Shamu CE; Williams EH; Wrobel D; Sorger PK; Heiser LM; Gray JW; Korkola JE; Mills GB; LaBarge M; Feiler HS; Dane MA; Bucher E; Nederlof M; Sudar D; Gross S; Kilburn DF; Smith R; Devlin K; Margolis R; Derr L; Lee A; Pillai A Cell Syst; 2018 Jan; 6(1):13-24. PubMed ID: 29199020 [TBL] [Abstract][Full Text] [Related]
8. A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles. Subramanian A; Narayan R; Corsello SM; Peck DD; Natoli TE; Lu X; Gould J; Davis JF; Tubelli AA; Asiedu JK; Lahr DL; Hirschman JE; Liu Z; Donahue M; Julian B; Khan M; Wadden D; Smith IC; Lam D; Liberzon A; Toder C; Bagul M; Orzechowski M; Enache OM; Piccioni F; Johnson SA; Lyons NJ; Berger AH; Shamji AF; Brooks AN; Vrcic A; Flynn C; Rosains J; Takeda DY; Hu R; Davison D; Lamb J; Ardlie K; Hogstrom L; Greenside P; Gray NS; Clemons PA; Silver S; Wu X; Zhao WN; Read-Button W; Wu X; Haggarty SJ; Ronco LV; Boehm JS; Schreiber SL; Doench JG; Bittker JA; Root DE; Wong B; Golub TR Cell; 2017 Nov; 171(6):1437-1452.e17. PubMed ID: 29195078 [TBL] [Abstract][Full Text] [Related]
9. Drug Effect Prediction by Integrating L1000 Genomic and Proteomic Big Data. Chen W; Zhou X Methods Mol Biol; 2019; 1939():287-297. PubMed ID: 30848468 [TBL] [Abstract][Full Text] [Related]
10. Data Portal for the Library of Integrated Network-based Cellular Signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data. Koleti A; Terryn R; Stathias V; Chung C; Cooper DJ; Turner JP; Vidovic D; Forlin M; Kelley TT; D'Urso A; Allen BK; Torre D; Jagodnik KM; Wang L; Jenkins SL; Mader C; Niu W; Fazel M; Mahi N; Pilarczyk M; Clark N; Shamsaei B; Meller J; Vasiliauskas J; Reichard J; Medvedovic M; Ma'ayan A; Pillai A; Schürer SC Nucleic Acids Res; 2018 Jan; 46(D1):D558-D566. PubMed ID: 29140462 [TBL] [Abstract][Full Text] [Related]
11. Chromatin proteomics reveals novel combinatorial histone modification signatures that mark distinct subpopulations of macrophage enhancers. Soldi M; Mari T; Nicosia L; Musiani D; Sigismondo G; Cuomo A; Pavesi G; Bonaldi T Nucleic Acids Res; 2017 Dec; 45(21):12195-12213. PubMed ID: 28981749 [TBL] [Abstract][Full Text] [Related]
12. Signatures of cell death and proliferation in perturbation transcriptomics data-from confounding factor to effective prediction. Szalai B; Subramanian V; Holland CH; Alföldi R; Puskás LG; Saez-Rodriguez J Nucleic Acids Res; 2019 Nov; 47(19):10010-10026. PubMed ID: 31552418 [TBL] [Abstract][Full Text] [Related]
13. L1000CDS Duan Q; Reid SP; Clark NR; Wang Z; Fernandez NF; Rouillard AD; Readhead B; Tritsch SR; Hodos R; Hafner M; Niepel M; Sorger PK; Dudley JT; Bavari S; Panchal RG; Ma'ayan A NPJ Syst Biol Appl; 2016; 2():16015-. PubMed ID: 28413689 [TBL] [Abstract][Full Text] [Related]
14. Metabolic labeling in middle-down proteomics allows for investigation of the dynamics of the histone code. Sidoli S; Lu C; Coradin M; Wang X; Karch KR; Ruminowicz C; Garcia BA Epigenetics Chromatin; 2017 Jul; 10(1):34. PubMed ID: 28683815 [TBL] [Abstract][Full Text] [Related]
15. Drug-induced cell viability prediction from LINCS-L1000 through WRFEN-XGBoost algorithm. Lu J; Chen M; Qin Y BMC Bioinformatics; 2021 Jan; 22(1):13. PubMed ID: 33407085 [TBL] [Abstract][Full Text] [Related]
16. Dex-Benchmark: datasets and code to evaluate algorithms for transcriptomics data analysis. Xie Z; Chen C; Ma'ayan A PeerJ; 2023; 11():e16351. PubMed ID: 37953774 [TBL] [Abstract][Full Text] [Related]
17. Ontological representation, integration, and analysis of LINCS cell line cells and their cellular responses. Ong E; Xie J; Ni Z; Liu Q; Sarntivijai S; Lin Y; Cooper D; Terryn R; Stathias V; Chung C; Schürer S; He Y BMC Bioinformatics; 2017 Dec; 18(Suppl 17):556. PubMed ID: 29322930 [TBL] [Abstract][Full Text] [Related]
18. Systematic Quality Control Analysis of LINCS Data. Cheng L; Li L CPT Pharmacometrics Syst Pharmacol; 2016 Nov; 5(11):588-598. PubMed ID: 27796074 [TBL] [Abstract][Full Text] [Related]
19. Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers. Vermeulen M; Eberl HC; Matarese F; Marks H; Denissov S; Butter F; Lee KK; Olsen JV; Hyman AA; Stunnenberg HG; Mann M Cell; 2010 Sep; 142(6):967-80. PubMed ID: 20850016 [TBL] [Abstract][Full Text] [Related]
20. An automated platform for analysis of phosphoproteomic datasets: application to kidney collecting duct phosphoproteins. Hoffert JD; Wang G; Pisitkun T; Shen RF; Knepper MA J Proteome Res; 2007 Sep; 6(9):3501-8. PubMed ID: 17683130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]